OpenLobby.EU
Explore

Evaluation of the implementation of the EU Drugs Strategy and of the EU Drugs Action Plan 2021-2025

Home affairs

The Commission is going to evaluate the implementation of the current EU drugs strategy and the related action plan. This evaluation should identify lessons learned and provide recommendations on potential improvements/changes in the EU drugs policy.

Links

Public consultation

ID: 14015

Lobbying Activity

5 responses

Consultation response

European Community Shipowners' Associations, 16 Jan 2024

ECSA represents 21 national shipowners associations based in the EU and Norway. European shipowners control 39.5% of the global commercial fleet, contribute 149 billion euros per year to the EU GDP and provide 2 million Europeans with careers both on board and ashore. ECSA strives for a regulatory…

Consultation response

Danish Shipping, 16 Jan 2024

As Danish Shipping represents member companies operating in global maritime shipping, we strongly support EUs efforts in addressing the challenges created by drugs trafficking. However, due to the complex issue of these challenges, it is important to coordinate across EUs various initiatives. EU…

Consultation response

Comunità San Patrignano Società Cooperativa Sociale, 15 Jan 2024

Founded in 1978, San Patrignano is one of Europe's largest therapeutic communities, welcoming youngsters and adults with SUD. San Patrignano does not accept money from its residents or their families: 65% of the funds necessary to run SP come from the communitys activities, following a principle of…

Consultation response

World Federation Against Drugs, 15 Jan 2024

WFAD is an umbrella organisation, based in Sweden, with European and International membership. With 425 member organisations in 69 countries our common aims are to strengthen prevention, increase access to treatment and promote recovery. WFAD places particular emphasis on the rights and needs of…

Consultation response

Europe for Action on Drugs, 11 Jan 2024

EURAD is a European drug policy network that advocates for evidence-based prevention, treatment, and recovery in European drug policy. We welcome the opportunity to provide feedback on the implementation of the EU Drugs Action Plan 2021-2025. The EU Drugs Action Plan offers a comprehensive approach…